129 related articles for article (PubMed ID: 22371553)
1. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.
Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ
J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553
[TBL] [Abstract][Full Text] [Related]
2. Significant immunohistochemical expression of human chorionic gonadotropin in high-grade osteosarcoma is rare, but may be associated with clinically elevated serum levels.
Lee AF; Pawel BR; Sullivan LM
Pediatr Dev Pathol; 2014; 17(4):278-85. PubMed ID: 24856811
[TBL] [Abstract][Full Text] [Related]
3. Ectopic production of β-hCG by osteosarcoma: a case report and review of the literature.
Oshrine BR; Sullivan LM; Balamuth NJ
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e202-6. PubMed ID: 24072248
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
5. Ezrin expression predicts survival in stage IIB osteosarcomas.
Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
[TBL] [Abstract][Full Text] [Related]
6. [Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up].
Werner M; Fuchs N; Salzer-Kuntschik M; Winkler K; Delling G
Pathologe; 1996 Jan; 17(1):35-43. PubMed ID: 8685094
[TBL] [Abstract][Full Text] [Related]
7. P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy.
Borys D; Canter RJ; Hoch B; Martinez SR; Tamurian RM; Murphy B; Bishop JW; Horvai A
Hum Pathol; 2012 Nov; 43(11):1948-54. PubMed ID: 22578565
[TBL] [Abstract][Full Text] [Related]
8. Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.
Ordóñez NG; Ayala AG; Raymond AK; Plager C; Benjamin RS; Samaan NA
Arch Pathol Lab Med; 1989 Apr; 113(4):416-9. PubMed ID: 2468324
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
10. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
[TBL] [Abstract][Full Text] [Related]
11. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
13. Spinal intradural primary germ cell tumour--review of literature and case report.
Biswas A; Puri T; Goyal S; Gupta R; Eesa M; Julka PK; Rath GK
Acta Neurochir (Wien); 2009 Mar; 151(3):277-84. PubMed ID: 19240975
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
[TBL] [Abstract][Full Text] [Related]
15. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
16. [Place of the pathologist in the management of primary bone tumors (osteosarcoma and Ewing's family tumors after neoadjuvant treatment)].
Gomez-Brouchet A; Bouvier C; Decouvelaere AV; Larousserie F; Aubert S; Leroy X; Guinebretière JM; Coulomb A; Cassagnau E; de Muret A; Audard V; Marie B; de Pinieux G
Ann Pathol; 2011 Dec; 31(6):455-65. PubMed ID: 22172118
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression in osteosarcoma.
Charity RM; Foukas AF; Deshmukh NS; Grimer RJ
Clin Orthop Relat Res; 2006 Jul; 448():193-8. PubMed ID: 16826116
[TBL] [Abstract][Full Text] [Related]
18. High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.
Leidinger B; Bielack S; Koehler G; Vieth V; Winkelmann W; Gosheger G
J Cancer Res Clin Oncol; 2004 Jun; 130(6):357-61. PubMed ID: 15042358
[TBL] [Abstract][Full Text] [Related]
19. KAI-1 expression in pediatric high-grade osteosarcoma.
Leavey PJ; Timmons C; Frawley W; Lombardi D; Ashfaq R
Pediatr Dev Pathol; 2006; 9(3):219-24. PubMed ID: 16944980
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
